VERACYTE INC

NASDAQ: VCYT (Veracyte, Inc.)

Last update: 28 Nov, 12:07AM

47.71

-1.67 (-3.38%)

  • 1D -3.38%
  • 5D 0.78%
  • 1M 14.41%
  • 6M 71.31%
  • YTD 17.98%
  • 1Y 11.58%
  • 5Y -22.90%
Previous Close 49.38
Open 48.99
Volume 1,030,082
Avg. Volume (3M) 987,587
Market Cap 3,771,436,032
Price / Earnings (TTM) 125.55
Price / Earnings (Forward) 31.85
Price / Sales 7.73
Price / Book 3.00
52 Weeks Range
22.61 (-52%) — 50.71 (6%)
Earnings Date 4 Nov 2025
Profit Margin 7.13%
Operating Margin (TTM) 7.03%
Diluted EPS (TTM) 0.420
Quarterly Revenue Growth (YOY) 18.20%
Total Debt/Equity (MRQ) 4.23%
Current Ratio (MRQ) 5.10
Operating Cash Flow (TTM) 89.42 M
Levered Free Cash Flow (TTM) 76.93 M
Return on Assets (TTM) 1.94%
Return on Equity (TTM) 2.86%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Bullish Mixed
Diagnostics & Research (Global) Bullish Mixed
Stock Veracyte, Inc. Bullish Bullish

AIStockmoo Score

-0.8
Analyst Consensus -1.5
Insider Activity -1.5
Price Volatility -5.0
Technical Moving Averages 0.0
Technical Oscillators 4.0
Average -0.80

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
VCYT 4 B - 125.55 3.00
EXAS 19 B - - 7.68
GH 14 B - - 55.67
RDNT 6 B - - 5.91
NEO 2 B - - 1.86
ATLN 124 M - - 12.93

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.
Sector Healthcare
Industry Diagnostics & Research
Investment Style Small Growth
% Held by Insiders 0.54%
% Held by Institutions 107.98%
52 Weeks Range
22.61 (-52%) — 50.71 (6%)
Price Target Range
43.00 (-9%) — 48.00 (0%)
High 48.00 (Morgan Stanley, 0.61%) Sell
48.00 (UBS, 0.61%) Buy
Median 45.00 (-5.68%)
Low 43.00 (Canaccord Genuity, -9.87%) Hold
Average 45.50 (-4.63%)
Total 4 Buy, 1 Hold, 1 Sell
Avg. Price @ Call 44.36
Firm Date Target Price Call Price @ Call
Morgan Stanley 02 Dec 2025 48.00 (0.61%) Sell 46.16
11 Nov 2025 40.00 (-16.16%) Sell 42.66
Canaccord Genuity 05 Nov 2025 43.00 (-9.87%) Hold 46.04
20 Oct 2025 40.00 (-16.16%) Hold 36.65
Guggenheim 05 Nov 2025 45.00 (-5.68%) Buy 46.04
Needham 05 Nov 2025 44.00 (-7.78%) Buy 46.04
UBS 05 Nov 2025 48.00 (0.61%) Buy 46.04
Freedom Capital Markets 17 Oct 2025 45.00 (-5.68%) Buy 35.83
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
JONES EVAN/ FA - 49.38 -1,106 -54,614
LEITE JOHN - 49.38 -2,808 -138,659
Aggregate Net Quantity -3,914
Aggregate Net Value ($) -193,273
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 49.38
Name Holder Date Type Quantity Price Value ($)
LEITE JOHN Officer 25 Nov 2025 Automatic sell (-) 2,808 49.38 138,659
JONES EVAN/ FA Director 25 Nov 2025 Automatic sell (-) 1,106 49.38 54,614

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria